ATYR
aTYR PHARMA INC
-0.01 (-1.74%)0.38USD410K成交股數37.0M市值–本益比(近四季)194.8股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | 0.00 | 190K | 0.00-100% | 0.00 | 0.00-100% | 0.00 | 235K | 0.00 | 353K | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 6.7M | 7.3M | 10.9M | 22.1M | 15.4M | 11.8M | 14.8M | 14.0M | 13.4M | 12.8M | 10.3M | 9.8M |
| 銷售管理費用 | 4.1M | 4.1M | 3.9M | 4.8M | 4.9M | 4.0M | 3.3M | 3.3M | 3.5M | 3.2M | 2.6M | 3.7M |
| 營業利益 | −10.9M-46% | −11.4M-27% | −14.8M-18% | −26.7M+54% | −20.3M+22% | −15.8M-1% | −18.1M+44% | −17.3M+28% | −16.6M | −16.0M | −12.6M | −13.6M |
| 營業利益率 | – | – | – | -14,076.3% | – | – | – | – | -7,079.1% | – | -3,573.7% | – |
| 稅後淨利 | −10.3M-47% | −10.8M-27% | −14.0M-19% | −25.7M+58% | −19.5M+26% | −14.9M+1% | −17.3M+52% | −16.3M+32% | −15.5M | −14.8M | −11.3M | −12.3M |
| 淨利率 | – | – | – | -13,549.5% | – | – | – | – | -6,591.9% | – | -3,212.5% | – |
| 稀釋 EPS | -0.11-50% | -0.11-35% | -0.15-35% | -0.26+13% | -0.22-4% | -0.17-26% | -0.23+15% | -0.23+5% | -0.23 | -0.23 | -0.20 | -0.22 |
| 稀釋股數 | 98.1M | 98.0M | 93.0M | 97.2M | 90.1M | 86.5M | 75.8M | 72.3M | 66.1M | 53.6M | 57.9M | 55.1M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 16.2M | 10.0M | 10.7M | 6.2M | 17.2M | 10.4M | 11.5M | 6.8M | 6.8M | 22.5M | 9.8M | 12.3M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 69.8M | 79.7M | 93.0M | 107M | 102M | 97.2M | 91.6M | 106M | 113M | 121M | 125M | 133M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | 48.8M | 57.9M | 67.5M | 80.2M | 74.8M | 75.1M | 65.3M | 81.6M | 84.5M | 90.7M | 98.4M | 106M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −12.5M-19% | – | – | – | −15.4M | – | – | −22.4M | – | – | – |
| 資本支出 | – | 138K | – | – | – | 0.00 | – | – | 17K | – | – | – |
| 自由現金流 | – | −12.7M-18% | – | – | – | −15.4M | – | – | −22.4M | – | – | – |
| 折舊攤銷 | – | 162K | – | – | – | 167K | – | – | 178K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | -9,530.6% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 200K
| Collaboration Revenue | 200K | 100.0% | 0.0% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 190K | -19.1% | −74.1M | -39,009.5% | -0.80 | −62.1M |
| FY2024 | 235K | -33.4% | −64.0M | -27,243.8% | -0.86 | −69.2M |
| FY2023 | 353K | -96.6% | −50.4M | -14,274.5% | -0.94 | −37.4M |
| FY2022 | 10.4M | – | −45.3M | -436.5% | -1.60 | −43.5M |
| FY2021 | 0.00 | -100.0% | −33.8M | –% | -1.77 | −33.3M |
| FY2020 | 10.5M | +2377.5% | −16.2M | -155.2% | -1.77 | −15.5M |
| FY2019 | 422K | – | −16.2M | -3,844.5% | -7.03 | −20.1M |
| FY2018 | – | – | −34.5M | –% | -16.11 | −31.7M |